ArticleCureus2026
Synchronous Lobular Breast Cancer and Lung Adenocarcinoma: Α Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synchronous breast and lung cancer (SBLC) is a rare entity posing great challenges in diagnosis and treatment. A 58-year-old female was referred to the breast department of our hospital with a palpable mass in the right breast. Mammography, ultrasound, and magnetic resonance (MR) imaging revealed bilateral, multifocal breast lesions. Core needle biopsy (CNB) revealed pleomorphic lobular breast cancer in the right breast and ductal carcinoma in situ (DCIS) in the left breast. Staging positron emission tomography-computed tomography (PET-CT) showed a suspicious lesion in the left lung. CT-guided biopsy revealed lung adenocarcinoma. According to the multidisciplinary team (MDT) decision, the patient underwent a staged approach. First, she was scheduled for bilateral mastectomy and right sentinel lymph node biopsy (SLNB). One month later, she underwent a left upper lobectomy and lymphadenectomy through a left posterior mini-thoracotomy. At present, two years later, the patient is currently in remission. Thus far, there are no clear and unified treatment guidelines for SBLC. Therefore, such cases should be discussed in MDT meetings, taking into account the stage of each cancer, the morbidity and mortality of each therapeutic approach, together with the patient's comorbidity and preference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.